Search

everythinglearnresearchcommunity

for

Search:↓

Dexamethasone increases androgen receptor activity in scalp cells, which might explain stress-related hair loss.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

A compound from Calophyllum inophyllum L. leaf may help treat non-small cell lung cancer.

Enfortumab vedotin can cause skin issues, especially in older males, needing early monitoring.

New vitamin D3 forms need the vitamin D receptor to reduce fibrosis in human cells.

A specific gene mutation causes vitamin D resistance, but certain vitamin D analogs might help.

LRIG1 protein affects hair growth by regulating skin receptors, leading to hair loss when overexpressed.

Blocking EGFR in skin cells doesn't majorly increase inflammation markers.

Correcting EDA fibronectin organization and YAP translocation can improve wound healing in fibrotic conditions.

Adipose stem cell exosomes can effectively reduce facial redness and improve skin health in atopic dermatitis patients.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

Estrogen increases blood vessel growth factor production, while testosterone blocks this increase.

The compound 4c showed strong potential as an anticancer agent.

Erlotinib can cause persistent excessive hair growth.

Blocking Wnt/β-catenin signaling with EGF receptor is necessary for proper hair growth.

Testosterone reduces knee movement, while flutamide and finasteride increase it.

Doxycycline helps prevent skin issues from erlotinib in lung cancer patients.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

Early diagnosis and treatment of EGFR inhibitor-induced folliculitis decalvans can prevent permanent hair loss.

Nelfb is crucial for forming skin fat tissue by regulating genes needed for fat cell development.

The protein ER71/ETV2 helps regrow hair after chemotherapy by improving the growth of new blood vessels.

A new treatment for hair loss shows promise with fewer side effects.

EGFR is essential for organized skin nerve growth and branching.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

Nano-liposome-bound EGF can delay hair growth in rats.

EGFR-targeted cancer therapy can cause skin issues starting at hair follicles, leading to inflammation.

Optimizing the structure of a specific compound greatly improved its effectiveness and precision for treating diabetic complications.

Scientists made a chemical (compound 4e) that can be applied on skin to reduce oil production, which can help with acne, but it might cause skin sensitivity to light.